Live feed
Filing
SC 13G
SC 13G0001013594-21-000722·Madison Avenue Partners, LP
Schedule 13G ownership disclosure
THERAVANCE BIOPHARMA INC
Security class unavailable · CUSIP: G8807B106
Event date: 2021-09-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001013594-21-000722
- Form type
- SC 13G
- Filer
- Madison Avenue Partners, LP
- CIK
- CIK 1801265
- Filed
- Sep 27, 2021
- Reporting period
- Sep 15, 2021
- Description
- Schedule 13G beneficial ownership